Moreover, unlike Garcia-Murillas et al.10, the relative proportion of ctDNA (as Mean Allele Frequency) in the plasma at baseline prior to chemotherapy was strongly associated with tumor features such as tumor size, grade, stage, nodal status, and response to NAC, but not when only the TP53 variants were used. Here, TP53 is linked to neoplasm.